Literature DB >> 24778048

The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.

Yusuke Yamamoto1, Hisashi Ikoma, Ryo Morimura, Hirotaka Konishi, Yasutoshi Murayama, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Takeshi Kubota, Masayoshi Nakanishi, Daisuke Ichikawa, Hitoshi Fujiwara, Kazuma Okamoto, Chouhei Sakakura, Toshiya Ochiai, Eigo Otsuji.   

Abstract

BACKGROUND: The prognostic value of lymph node (LN) status in patients who underwent resection for pancreatic cancer (PC) was examined in the present study. PATIENTS AND METHODS: Fifty-six patients who underwent macroscopic curative resection for PC were analyzed. Twelve factors, including the number of LN metastases, LN ratio, and N category according to the Japanese Pancreatic Society classification, were analyzed using univariate and multivariate analysis.
RESULTS: The optimal cut-off value was 0.2 for the LN ratio. Positive surgical margins (p=0.022) and LN ratio ≥0.2 (p=0.017) were identified as independent prognostic factors. Among the 33 patients with regional LN metastasis, patients with LN ratio ≥0.2 had significantly worse prognosis than those with LN ratio <0.2 (median survival time 14 vs. 26 months, p=0.048), however, the differences in survival between those with N1 and those with N2 by Japanese Pancreatic Society classification were not statistically significant (p=0.85).
CONCLUSION: The LN ratio might be more useful than other parameters as a predictor for survival after resection of PC.

Entities:  

Keywords:  Pancreatic cancer; lymph node metastasis; lymph node ratio; pancreatectomy

Mesh:

Year:  2014        PMID: 24778048

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  Clinical Implication of Node-negative Resectable Pancreatic Cancer.

Authors:  Mihoko Yamada; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Katsuhisa Ohgi; Takeshi Aramaki; Masahiro Endo; Katsuhiko Uesaka
Journal:  Ann Surg Oncol       Date:  2021-01-15       Impact factor: 5.344

3.  Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.

Authors:  Rong Lin; Chao-Qun Han; Wei-Jun Wang; Jun Liu; Wei Qian; Zhen Ding; Xiao-Hua Hou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

4.  The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.

Authors:  Norio Yukawa; Toru Aoyama; Hiroshi Tamagawa; Ayako Tamagawa; Yosuke Atsumi; Shinnosuke Kawahara; Yukio Maezawa; Kazuki Kano; Masaaki Murakawa; Keisuke Kazama; Masakatsu Numata; Takashi Oshima; Munetaka Masuda; Yasushi Rino
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 5.  A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.

Authors:  M Elshaer; G Gravante; M Kosmin; A Riaz; A Al-Bahrani
Journal:  Ann R Coll Surg Engl       Date:  2016-11-21       Impact factor: 1.891

6.  Development of Nomograms for Predicting Prognosis of Pancreatic Cancer after Pancreatectomy: A Multicenter Study.

Authors:  So Jeong Yoon; Boram Park; Jaewoo Kwon; Chang-Sup Lim; Yong Chan Shin; Woohyun Jung; Sang Hyun Shin; Jin Seok Heo; In Woong Han
Journal:  Biomedicines       Date:  2022-06-07

7.  Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer.

Authors:  Han-xiang Zhan; Jian-wei Xu; Lei Wang; Guang-yong Zhang; San-yuan Hu
Journal:  World J Surg Oncol       Date:  2015-03-13       Impact factor: 2.754

8.  Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.

Authors:  Christelle d'Engremont; Dewi Vernerey; Anne-Laure Pointet; Gaël Simone; Francine Fein; Bruno Heyd; Stéphane Koch; Lucine Vuitton; Stefano Kim; Marine Jary; Najib Lamfichek; Celia Turco; Zaher Lakkis; Anne Berger; Franck Bonnetain; Julien Taieb; Philippe Bachellier; Christophe Borg
Journal:  BMC Cancer       Date:  2016-10-26       Impact factor: 4.430

9.  Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.

Authors:  Chao Wu; Sheng Zhong Hou; Zuowei Wu; Xing Huang; Zihe Wang; Bole Tian
Journal:  BMC Cancer       Date:  2021-05-27       Impact factor: 4.430

10.  Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?

Authors:  G Lahat; N Lubezky; F Gerstenhaber; E Nizri; M Gysi; M Rozenek; Y Goichman; I Nachmany; R Nakache; I Wolf; J M Klausner
Journal:  World J Surg Oncol       Date:  2016-09-29       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.